Intismeran autogene
2
MENTIONS
2
EPISODES
2
PODCASTS
Search complete. 2 mentions across 2 episodes found for "Intismeran autogene".
Oct 13, 2026
Tallulah LemerleHOST
Today, we're diving into Tempest AI's recent collaboration announcement.
Tallulah LemerleHOST
On October 7th, Tempest AI revealed an expanded multi-year partnership to support the potential commercialization of Intismarin autogene V940, also known as mRNA-4157.
Tallulah LemerleHOST
Matthew, what does this mean for Tempest AI?
MatthewHOST
Thanks, Talula.
Lennard LeeGUEST
Yeah, so let's just compare the two.
Lennard LeeGUEST
Moderna picked for the first trial for V940 melanoma.
Lennard LeeGUEST
That is a type of cancer which responds very well to immune therapies and it has a lot of mutations.
Lennard LeeGUEST
BioNTech picked bowel cancer, a harder street cancer, less mutations, less immune active.